Spurious increase in serum chromogranin A: the role of heterophilic antibodies.
The aim of the study was to examine the prevalence of heterophilic antibody (HAb) interference on serum chromogranin A (CgA) measurements. Serum CgA was measured in 672 serum samples before and following incubation in heterophilic antibody blocking tubes (HBTs). Results showing more than 3 and 5 SD percentage difference from the original result were considered to be affected by possible or definite HAb interference, respectively. All possible interferences were confirmed or excluded by non-linear or linear dilution tests. Following HBT treatment, CgA concentrations fell >3 SD percent compared with the original result in seven specimens, six of which also showed non-linear dilution (0.9%). A clinically relevant increase in serum CgA occurred in five patients (0.7%). No samples showed a significant increase of >3 SD percent following HBT treatment. Interference from HAb occurred in up to 0.9% of sera tested for serum CgA. If an increased CgA result does not fit the clinical picture, pretreatment of serum in HBT tubes may prevent unwarranted investigations or therapies.